# Terbinafine

NDC: 69097-859
Generic name: Terbinafine
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20160627

FDA application: ANDA077533

## Active ingredients

- TERBINAFINE HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-859"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-859
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=18b16aad-1877-4b07-b532-f0ef4843af91